Pulmonary toxicity of carbon nanotubes and asbestos - Similarities and differences

Advanced Drug Delivery Reviews

Volumn 65, Issue 15, 2013, Pages 2078-2086

  Donaldson, Ken ^a   Poland, Craig A ^b   Murphy, Fiona A ^c   MacFarlane, Marion ^c   Chernova, Tatyana ^c   Schinwald, Anja ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b INSTITUTE OF OCCUPATIONAL MEDICINE   (United Kingdom)

^c MRC TOXICOLOGY UNIT   (United Kingdom)

Author keywords

Asbestos; Biopersistence; Carbon nanotubes; Diameter; Fibres; Length; Lungs; Mesothelioma; Nanofibres; Pleura

Indexed keywords

BIOPERSISTENCE; DIAMETER; LENGTH; LUNGS; MESOTHELIOMA; PLEURA;

CARBON NANOTUBES; FIBERS; NANOFIBERS; PATHOLOGY; RESEARCH; TUMORS;

ASBESTOS;

ASBESTOS; CARBON NANOTUBE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE; MULTI WALLED NANOTUBE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; SINGLE WALLED NANOTUBE; TUMOR NECROSIS FACTOR ALPHA;

ANCHORAGE INDEPENDENT GROWTH; ASBESTOSIS; BIOACCUMULATION; CARCINOGENICITY; CELL INFILTRATION; CELL TRANSFORMATION; CHEMICAL COMPOSITION; CHEMICAL STRUCTURE; ENVIRONMENTAL EXPOSURE; ENZYME ACTIVATION; EPITHELIAL MESENCHYMAL TRANSITION; FIBROSING ALVEOLITIS; GENOTOXICITY; HEALTH HAZARD; IMMUNOSTIMULATION; INFLAMMATION; INFLAMMATORY CELL; LUNG ALVEOLUS EPITHELIUM; LUNG FIBROSIS; LUNG TOXICITY; LUNG TUMOR; MESOTHELIOMA; MESOTHELIUM CELL; NEOPLASM; OXIDATIVE STRESS; PATHOGENICITY; PERITONEAL CAVITY; PHAGOCYTOSIS; PHYSICAL PARAMETERS; PLEURA CAVITY; PNEUMONIA; PRIORITY JOURNAL; REVIEW; SOLUBILITY; STRUCTURE ACTIVITY RELATION;

ASBESTOS; BIOPERSISTENCE; CARBON NANOTUBES; DIAMETER; FIBRES; LENGTH; LUNGS; MESOTHELIOMA; NANOFIBRES; PLEURA;

ANIMALS; ASBESTOS; ENVIRONMENTAL EXPOSURE; HUMANS; INFLAMMATION; INHALATION EXPOSURE; LUNG; LUNG DISEASES; NANOTUBES, CARBON; OXIDATIVE STRESS; PLEURAL DISEASES;

EID: 84888866200     PISSN: 0169409X     EISSN: 18728294     Source Type: Journal    
DOI: 10.1016/j.addr.2013.07.014     Document Type: Review

References (88)

1. WHO IARC IARC monographs on the evaluation of carcinogenic risks to humans. Volume 81 Man-made Vitreous Fibres 2002, IARC Lyon, (Ref Type: Generic).
2. Donaldson K. The inhalation toxicology of p-aramid fibrils. Crit. Rev. Toxicol. 2009, 39:487-500.
3. Donaldson K., Murphy F.A., Duffin R., Poland C.A. Asbestos, carbon nanotubes and the pleural mesothelium: a review of the hypothesis regarding the role of long fibre retention in the parietal pleura, inflammation and mesothelioma. Part Fibre Toxicol. 2010, 7:5.
4. Donaldson K., Duffin R., Murphy F.A., Poland C. Utilising the concept of the biologically effective dose to define the particle and fibre hazards of carbon nanotubes. Chapter 3. The Toxicology of Carbon Nanotubes 2012, 63-72. Cambridge University Press, Cambridge, (Ref Type: Generic). K. Donaldson, C.A. Poland, R. Duffin, J. Bonner (Eds.).
5. Poland C.A., Duffin R., Kinloch I., Maynard A., Wallace W.A., Seaton A., et al. Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. Nat. Nanotechnol. 2008, 3:423-428.
6. Murphy F.A., Poland C.A., Duffin R., Al Jamal K.T., Ali-Boucetta H., Nunes A., et al. Length-dependent retention of carbon nanotubes in the pleural space of mice initiates sustained inflammation and progressive fibrosis on the parietal pleura. Am. J. Pathol. 2011, 178:2587-2600.
7. Murphy F.A., Schinwald A., Poland C.A., Donaldson K. The mechanism of pleural inflammation by long carbon nanotubes: interaction of long fibres with macrophages stimulates them to amplify pro-inflammatory responses in mesothelial cells. Part Fibre Toxicol. 2012, 9:8.
8. Kamp D.W. Asbestos-induced lung diseases: an update. Transl. Res. 2009, 153:143-152.
9. Donaldson K. The inhalation toxicology of p-aramid fibrils. Critical Reviews. Toxicology 2009, ((Pre-print available on the web) Ref Type: Generic).
10. Kreyling W.G., Moller W., Semmler-Behnke M., Oberdorster G. Particle dosimetry: deposition and clearance from the respiratory tract and translocation to extra-pulmonary sites. Chapter 3. Particle Toxicology 2007, 47-74. CRC Press, Boca Raton USA, (Ref Type: Generic). K. Donaldson, P. Borm (Eds.).
11. Walton W.H. Chapter 5. Airborne dusts. Mineral Fibers and Health 1991, 55-77. CRC Press, Boca Raton, FL, (Ref Type: Generic). D. Liddell, K. Miller (Eds.).
12. Stanton M.F., Laynard M., Tegeris A., Miller E., May M. Kent: carcinogenicity of fibrous glass: pleural response in the rat in relation to fiber dimension. J. Natl. Cancer Inst. 1977, 58:587-603.
13. Stanton M.F., Layard M., Tegeris A., Miller E., May M., Morgan E., et al. Relation of particle dimension to carcinogenicity in amphibole asbestoses and other fibrous minerals. J. Natl. Cancer Inst. 1981, 67:965-975.
14. Davis J.G., Addison J., Bolton R.E., Donaldson K., Jones A.D., Smith T. The pathogenicity of long versus short fiber samples of amosite asbestos administered to rats by inhalation and intraperitoneal injection. Br. J. Exp. Pathol. 1986, 67:415-430.
15. Adamson I.Y., Letourneau H.L., Bowden D.H. Comparison of alveolar and interstitial macrophages in fibroblast stimulation after silica and long or short asbestos. 1. Lab. Invest. 1991, 64:339-344.
16. Adamson I.Y., Bakowska J., Bowden D.H. Mesothelial cell proliferation after instillation of long or short asbestos fibers into mouse lung 4. Am. J. Pathol. 1993, 142:1209-1216.
17. Goodglick L.A., Kane A.B. Cytotoxicity of long and short crocidolite asbestos fibers in vitro and in vivo. Cancer Res. 1990, 50:5153-5163.
18. Donaldson K., Brown G.M., Brown D.M., Bolton R.E., Davis J.G. Inflammation generating potential of long and short fiber amosite asbestos samples. Br. J. Ind. Med. 1989, 46:271-276.
19. Moalli P.A., Macdonald J.L., Goodglick L.A., Kane A.B. Acute injury and regeneration of the mesothelium in response to asbestos fibers. Am. J. Pathol. 1987, 128:426-445.
20. Donaldson K., Li X.Y., Dogra S., Miller B.G., Brown G.M. Asbestos-stimulated tumor-necrosis-factor release from alveolar macrophages depends on fiber length and opsonization. J. Pathol. 1992, 168:243-248.
21. Hill I.M., Beswick P.H., Donaldson K. Differential release of superoxide anions by macrophages treated with long and short-fiber amosite asbestos is a consequence of differential affinity for opsonin. Occup. Environ. Med. 1995, 52:92-96.
22. Donaldson K., Golyasnya N. Cytogenetic and pathogenic effects of long and short amosite asbestos. J. Pathol. 1995, 177:303-307.
23. Coin P.G., Roggli V.L., Brody A.R. Persistence of long, thin chrysotile asbestos fibers in the lungs of rats 4. Environ. Health Perspect 1994, 102(Suppl. 5):197-199.
24. Searl A., Buchanan D., Cullen R.T., Jones A.D., Miller B.G., Soutar C.A. Biopersistence and durability of nine mineral fibre types in rat lungs over 12months. Ann. Occup. Hyg. 1999, 43:143-153.
25. Poland C.A., Byrne F., Cho W.S., Prina-Mello A., Murphy F.A., Davies G.L., et al. Length-dependent pathogenic effects of nickel nanowires in the lungs and the peritoneal cavity. Nanotoxicology 2011, 6:899-911.
26. Schinwald A., Chernova T., Donaldson K. Use of silver nanowires to determine thresholds for fibre length-dependent pulmonary inflammation and inhibition of macrophage migration in vitro. 2012. Part Fibre Toxicol. 2012, 9(47). (Ref Type: Generic).
27. Giovanni M., Ambrosi A., Pumera M. Direct determination of bioavailable molybdenum in carbon nanotubes. Chemistry 2011, 17:1806-1810.
28. Cho W.S., Duffin R., Poland C.A., Duschl A., Oostingh G.J., MacNee W., et al. Differential pro-inflammatory effects of metal oxide nanoparticles and their soluble ions in vitro and in vivo; zinc and copper nanoparticles, but not their ions, recruit eosinophils to the lungs. Nanotoxicology 2011, 6:22-35.
29. Mcconnell E.E., Axten C., Hesterberg T.W., Chevalier J., Miiller W.C., Everitt J., et al. Studies on the inhalation toxicology of two fiberglasses and amosite asbestos in the Syrian golden hamster. Part II. Results of chronic exposure 1. Inhal. Toxicol. 1999, 11:785-835.
30. Hesterberg T.W., Anderson R., Bernstein D.M., Bunn W.B., Chase G.A., Jankousky A.L., et al. Product stewardship and science: safe manufacture and use of fiber glass. Regul. Toxicol. Pharmacol. 2012, 62:257-277.
31. Liu X., Hurt R.H., Kane A.B. Biodurability of single-walled carbon nanotubes depends on surface functionalization. Carbon N. Y. 2010, 48:1961-1969.
32. Allen B.L., Kotchey G.P., Chen Y., Yanamala N.V., Klein-Seetharaman J., Kagan V.E., et al. Mechanistic investigations of horseradish peroxidase-catalyzed degradation of single-walled carbon nanotubes. J. Am. Chem. Soc. 2009, 131:17194-17205.
33. Kagan V.E., Konduru N.V., Feng W., Allen B.L., Conroy J., Volkov Y., et al. Carbon nanotubes degraded by neutrophil myeloperoxidase induce less pulmonary inflammation. Nat. Nanotechnol. 2010, 5:354-359.
34. Osmond-McLeod M.J., Poland C.A., Murphy F., Waddington L., MOrris H., Hawkins S.C., et al. Durability and inflammogenic impact of carbon nanotubes compared with asbestos fibres. Part Fibre Toxicol. 2011, 8:15.
35. Donaldson K. Biological-activity of respirable industrial fibers treated to mimic residence in the lung. Toxicol. Lett. 1994, 72:299-305.
36. Kane A.B. Mechanisms of mineral fibre carcinogenesis. Mechanisms of Fibre Carcinogenesis 1996, 11-34. A.B. Kane, P. Boffetta, R. Saracci, J.D. Wilbourn (Eds.).
37. Muller J., Huaux F., Moreau N., Misson P., Heilier J.F., Delos M., et al. Respiratory toxicity of multi-wall carbon nanotubes 1. Toxicol. Appl. Pharmacol. 2005, 207:221-231.
38. Shvedova A.A., Kisin E.R., Mercer R., Murray A.R., Johnson V.J., Potapovich A.I., et al. Unusual inflammatory and fibrogenic pulmonary responses to single-walled carbon nanotubes in mice 1. Am. J. Physiol. Lung Cell. Mol. Physiol. 2005, 289:L698-L708.
39. Shvedova A.A., Kisin E.R., Murray A.R., Johnson V.J., Gorelik O., Arepalli S., et al. Inhalation versus aspiration of single walled carbon nanotubes in C57/Bl6 mice: inflammation, fibrosis, oxidative stress and mutagenesis. Am. J. Physiol. Lung Cell. Mol. Physiol. 2008, 295:L552-L565.
40. Lam C.W., James J.T., McCluskey R., Hunter R.L. Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90days after intratracheal instillation. Toxicol. Sci. 2004, 77:126-134.
41. Porter D.W., Hubbs A.F., Chen B.T., McKinney W., Mercer R.R., Wolfarth M.G., et al. Acute pulmonary dose-responses to inhaled multi-walled carbon nanotubes. Nanotoxicology 2012 [Epub ahead of print].
42. Mercer R.R., Hubbs A.F., Scabilloni J.F., Wang L., Battelli L.A., Friend S., et al. Pulmonary fibrotic response to aspiration of multi-walled carbon nanotubes. Part Fibre Toxicol. 2011, 8:21.
43. Donaldson K., Brown G.M., Brown D.M., Bolton R.E., Davis J.M. Inflammation generating potential of long and short fibre amosite asbestos samples 11. Br. J. Ind. Med. 1989, 46:271-276.
44. Mossman B.T., Churg A. Mechanisms in the pathogenesis of asbestosis and silicosis. Am. J. Respir. Crit. Care Med. 1998, 157:1666-1680.
45. Gilmour P.S., Brown D.M., Beswick P.H., MacNee W., Rahman I., Donaldson K. Free radical activity of industrial fibers: role of iron in oxidative. Environ. Health Perspect. 1997, 105:1313-1317.
46. Muller J., Huaux F., Fonseca A., Nagy J.B., Moreau N., Delos M., et al. Structural defects play a major role in the acute lung toxicity of multiwall carbon nanotubes: toxicological aspects. Chem. Res. Toxicol. 2008, 21:1698-1705.
47. -) from alveolar macrophages exposed to asbestiform and nonfibrous particles 2. Cancer Res. 1987, 47:1681-1686.
48. Brown D.M., Kinloch I.A., Bangert U., Windle A., Walter D.M., Walker G.S., et al. An in vitro study of the potential of carbon nanotubes and nanofibres to induce inflammatory mediators and frustrated phagocytosis. Carbon 2007, 45:1743-1756. (Ref Type: Generic).
49. Ye J., Shi X., Jones W., Rojanasakul Y., Cheng N., Schwegler-Berry D., et al. Critical role of glass fiber length in TNF-alpha production and transcription factor activation in macrophages. Am. J. Physiol. 1999, 276:L426-L434.
50. Hamilton R.F., Wu N., Porter D., Buford M., Wolfarth M., Holian A. Particle length-dependent titanium dioxide nanomaterials toxicity and bioactivity. Part Fibre Toxicol. 2009, 6:35.
51. Kamp D.W., Graceffa P., Pryor W.A., Weitzman S.A. The role of free radicals in asbestos-induced diseases. Free Radic. Biol. Med. 1992, 12:293-315. [Review] [212 refs].
52. Sargent L.M., Shvedova A.A., Hubbs A.F., Salisbury J.L., Benkovic S.A., Kashon M.L., et al. Induction of aneuploidy by single-walled carbon nanotubes. Environ. Mol. Mutagen. 2009, 50:708-717.
53. Driscoll K.E. Effects of fibres on cell proliferation, cell activation and gene expression. Mechanisms of Fibre Carcinogenesis. IARC Scientific Publication No 140 1996, 73-96. (Ref Type: Generic). A.B. Kane, P. Boffetta, R. Saracci, J.D. Wilbourn (Eds.).
54. Mutsaers S.E., Prele C.M., Brody A.R., Idell S. Pathogenesis of pleural fibrosis. Respirology 2004, 9:428-440.
55. Shinohara H. Distribution of lymphatic stomata on the pleural surface of the thoracic cavity and the surface topography of the pleural mesothelium in the golden hamster. Anat. Rec. 1997, 249:16-23.
56. Schinwald A., Murphy F.A., Prina-Mello A., Poland C.A., Byrne F., Movia D., et al. The threshold length for fiber-induced acute pleural inflammation: shedding light on the early events in asbestos-induced mesothelioma. Toxicol. Sci. 2012, 128:461-470.
57. Mueller N.C., Nowack B. Exposure modeling of engineered nanoparticles in the environment. Environ. Sci. Technol. 2008, 42:4447-4453.
58. Wagner J.C., Sleggs C.A., Marchand P. Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province 138. Br. J. Ind. Med. 1960, 17:260-271.
59. Owens M.W., Milligan S.A. Pleuritis and pleural effusions. Curr. Opin. Pulm. Med. 1995, 1:318-323.
60. Stanton M.F., Wrench C. Mechanisms of mesothelioma induction with asbestos and fibrous glass. J. Natl. Cancer Inst. 1972, 48:797-821. (Ref Type: Generic).
61. Stanton M.F. Some etiological considerations of fibre carcinogenesis. Biological Effects of Asbestos 1973, 289-294. WHO IARC Lyon 1973, (Ref Type: Generic). P. Bogovski, J.C. Gilson, V. Timbrell, J.C. Wagner (Eds.).
62. Timbrell V., Ashcroft T., Goldstein B., Heyworth F., Meurman L.O., Rendall R.E.G., et al. Relationships between retained amphibole fibres and fibrosis in human lung tissue specimens. Annals of Occupational Hygiene 1988, 32 (S1):323-340. (Ref Type: Generic).
63. Donaldson K., Poland C.A. Inhaled nanoparticles and lung cancer - what we can learn from conventional particle toxicology. Swiss Med. Wkly. Jun 19, 2012, 142:W13547.
64. Takagi A., Hirose A., Nishimura T., Fukumori N., Ogata A., Ohashi N., et al. Induction of mesothelioma in p53+/- mouse by intraperitoneal application of multi-wall carbon nanotube. J. Toxicol. Sci. 2008, 33:105-116.
65. Muller J., Delos M., Panin N., Rabolli V., Huaux F., Lison D. Absence of carcinogenic response to multi-wall carbon nanotubes in a 2-year bioassay in the peritoneal cavity of the rat. Toxicol. Sci. 2009, 110:442-448. (kfp100).
66. Fraire A.E., Greenberg S.D., Spjut H.J., Dodson R.F., Williams G., Lach-Pasko E., et al. Effect of erionite on the pleural mesothelium of the Fischer 344 rat. Chest 1997, 111:1375-1380.
67. Zanella C.L., Posada J., Tritton T.R., Mossman B.T. Asbestos causes stimulation of the extracellular signal-regulated kinase-1 mitogen-activated protein-kinase cascade after phosphorylation of the epidermal growth-factor receptor. Cancer Res. 1996, 56:5334-5338.
68. Shukla A., Timblin C., BeruBe K., Gordon T., McKinney W., Driscoll K., et al. Inhaled particulate matter causes expression of nuclear factor (NF)-kappaB-related genes and oxidant-dependent NF-kappaB activation in vitro. Am. J. Respir. Cell Mol. Biol. 2000, 23:182-187.
69. Zanella C.L., Timblin C.R., Cummins A., Jung M., Goldberg J., Raabe R., et al. Asbestos-induced phosphorylation of epidermal growth factor receptor is linked to c-fos and apoptosis. Am. J. Physiol. 1999, 277:L684-L693.
70. Ramos-Nino M.E., Timblin C.R., Mossman B.T. Mesothelial cell transformation requires increased AP-1 binding activity and ERK-dependent Fra-1 expression. Cancer Res. 2002, 62:6065-6069.
71. Pacurari M., Yin X.J., Zhao J., Ding M., Leonard S.S., Schwegler-Berry D., et al. Raw single-wall carbon nanotubes induce oxidative stress and activate MAPKs, AP-1, NF-kappaB, and Akt in normal and malignant human mesothelial cells. Environ. Health Perspect 2008, 116:1211-1217.
72. Yang H., Rivera Z., Jube S., Nasu M., Bertino P., Goparaju C., et al. Programmed necrosis induced by asbestos in human mesothelial cells causes high-mobility group box 1 protein release and resultant inflammation. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:12611-12616.
73. Broaddus V.C., Yang L., Scavo L.M., Ernst J.D., Boylan A.M. Asbestos induces apoptosis of human and rabbit pleural mesothelial cells via reactive oxygen species. J. Clin. Invest. 1996, 98:2050-2059.
74. Swain W.A., Faux S.P. Activation of p38 MAP kinase by crocidolite in mesothelial cells is dependent upon oxidative stress. Ann. Occup. Hyg. 2002, 46(Suppl. 1):136-139. (Ref Type: Generic).
75. Xu L., Flynn B.J., Ungar S., Pass H.I., Linnainmaa K., Mattson K., et al. Asbestos induction of extended lifespan in normal human mesothelial cells: interindividual susceptibility and SV40 T antigen. Carcinogenesis 1999, 20:773-783.
76. Lechner J.F., Tokiwa T., LaVeck M., Benedict W.F., Banks-Schlegel S., Yeager H., et al. Asbestos-associated chromosomal changes in human mesothelial cells. Proc. Natl. Acad. Sci. U. S. A. 1985, 82:3884-3888.
77. Wang Y., Faux S.P., Hallden G., Kirn D.H., Houghton C.E., Lemoine N.R., et al. Interleukin-1beta and tumour necrosis factor-alpha promote the transformation of human immortalised mesothelial cells by erionite. Int. J. Oncol. 2004, 25:173-178.
78. Wagner J.C., Skidmore J.W., Hill R.J., Griffiths D.M. Erionite exposure and mesotheliomas in rats. Br. J. Cancer 1985, 51:727-730.
79. Maltoni C., Minardi F., Morisi L. Pleural mesotheliomas in Sprague-Dawley rats by erionite: first experimental evidence. Environ. Res. 1982, 29:238-244.
80. Dikensoy O. Mesothelioma due to environmental exposure to erionite in Turkey. Curr. Opin. Pulm. Med. 2008, 14:322-325.
81. Yang H., Bocchetta M., Kroczynska B., Elmishad A.G., Chen Y., Liu Z., et al. TNF-alpha inhibits asbestos-induced cytotoxicity via a NF-kappaB-dependent pathway, a possible mechanism for asbestos-induced oncogenesis. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:10397-10402.
82. Sakamoto Y., Nakae D., Fukumori N., Tayama K., Maekawa A., Imai K., et al. Induction of mesothelioma by a single intrascrotal administration of multi-wall carbon nanotube in intact male Fischer 344 rats. J. Toxicol. Sci. 2009, 34:65-76.
83. Takagi A., Hirose A., Futakuchi M., Tsuda H., Kanno J. Dose-dependent mesothelioma induction by intraperitoneal administration of multi-wall carbon nanotubes in p53 heterozygous mice. Cancer Sci. 2012, 103:1440-1444.
84. Nagai H., Toyokuni S. Biopersistent fiber-induced inflammation and carcinogenesis: lessons learned from asbestos toward safety of fibrous nanomaterials. Arch. Biochem. Biophys. 2010, 502:1-7.
85. Park E.J., Roh J., Kim S.N., Kang M.S., Han Y.A., Kim Y., et al. A single intratracheal instillation of single-walled carbon nanotubes induced early lung fibrosis and subchronic tissue damage in mice. Arch. Toxicol. 2011, 85:1121-1131.
86. Yang M., Meng J., Cheng X., Lei J., Guo H., Zhang W., et al. Multiwalled carbon nanotubes interact with macrophages and influence tumor progression and metastasis. Theranostics 2012, 2:258-270.
87. Bremnes R.M., Al-Shibli K., Donnem T., Sirera R., Al-Saad S., Andersen S., et al. The role of tumor-infiltrating immune cells and chronic inflammation at the tumor site on cancer development, progression, and prognosis: emphasis on non-small cell lung cancer. J. Thorac. Oncol. 2011, 6:824-833.
88. Iliopoulos D., Jaeger S.A., Hirsch H.A., Bulyk M.L., Struhl K. STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer. Mol. Cell 2010, 39:493-506.